These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21041973)

  • 41. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction.
    Odar-Cederlöf I; Bjellerup P; Williams A; Blagg CR; Twardowski Z; Ting G; Kjellstrand CM
    Hemodial Int; 2006 Oct; 10(4):394-8. PubMed ID: 17014518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Highly sensitive cardiac troponin T in heart failure: comparison with echocardiographic parameters and natriuretic peptides.
    Kusumoto A; Miyata M; Kubozono T; Ikeda Y; Shinsato T; Kuwahata S; Fujita S; Takasaki K; Yuasa T; Hamasaki S; Tei C
    J Cardiol; 2012 Mar; 59(2):202-8. PubMed ID: 22266455
    [TBL] [Abstract][Full Text] [Related]  

  • 43. N-terminal pro brain natriuretic peptide as a cardiac biomarker in Japanese hemodialysis patients.
    Shimizu M; Doi S; Nakashima A; Naito T; Masaki T
    Int J Artif Organs; 2018 Mar; 41(3):135-143. PubMed ID: 29546814
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effects of multimodal combination dialysis on Klotho protein, FGF-23 and BNP in patients with maintenance hemodialysis].
    Deng X; Dai Q; Wan L; Tang L; Shu Y; Xiao H; Bi Y; Yang H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jul; 29(7):636-639. PubMed ID: 28743343
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cardiac troponins and left ventricular hypertrophy in hemodialysis patients].
    Petrović D; Obrenović R; Radovanović M; Stojimirović B
    Med Pregl; 2007; 60 Suppl 2():87-90. PubMed ID: 18928167
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Role of fibroblast growth factor 23 in the development of cardiovascular diseases in patients with end-stage renal failure on programmed hemodialysis].
    Dzgoeva FU; Sopoev MY; Bestaeva TL; Khamitsaeva OV; Ktsoeva FA; Sageeva RO
    Ter Arkh; 2016; 88(12):51-56. PubMed ID: 28139560
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibroblast growth factor 23 (FGF23) level is associated with ultrafiltration rate in patients on hemodialysis.
    Nishizawa Y; Hosoda Y; Horimoto A; Omae K; Ito K; Higuchi C; Sakura H; Nitta K; Ogawa T
    Heart Vessels; 2021 Mar; 36(3):414-423. PubMed ID: 33000285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
    Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD.
    Colbert G; Jain N; de Lemos JA; Hedayati SS
    Clin J Am Soc Nephrol; 2015 Mar; 10(3):515-29. PubMed ID: 25403922
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis.
    Kojima F; Uchida K; Ogawa T; Tanaka Y; Nitta K
    Int Urol Nephrol; 2008; 40(4):1067-74. PubMed ID: 18791804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction of malnutrition, N-terminal pro-B-type natriuretic peptide and ventricular remodeling in patients on maintenance hemodialysis.
    Lee YJ; Song BG; Kim MS; Cho S; Chun WJ; Oh JH; Kim SR
    Clin Nephrol; 2013 Apr; 79(4):253-60. PubMed ID: 23149248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brain natriuretic peptide in hemodialysis patients: predictive value for hemodynamic change during hemodialysis and cardiac function.
    Matayoshi T; Kato T; Nakahama H; Nakata H; Yoshihara F; Kamide K; Horio T; Nakamura S; Kawano Y
    Am J Nephrol; 2008; 28(1):122-7. PubMed ID: 17943021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two daytime icodextrin exchanges decrease brain natriuretic peptide levels and improve cardiac functions in continuous ambulatory peritoneal dialysis patients.
    Sav T; Inanc MT; Dogan A; Oymak O; Utas C
    Nephrology (Carlton); 2010 Apr; 15(3):307-12. PubMed ID: 20470299
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in Biomarker Profile and Left Ventricular Hypertrophy Regression: Results from the Frequent Hemodialysis Network Trials.
    Chan CT; Kaysen GA; Beck GJ; Li M; Lo J; Rocco MV; Kliger AS;
    Am J Nephrol; 2018; 47(3):208-217. PubMed ID: 29621747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled Trial.
    Higuchi T; Abe M; Yamazaki T; Okawa E; Ando H; Hotta S; Oikawa O; Kikuchi F; Okada K; Soma M
    Am J Kidney Dis; 2016 Feb; 67(2):260-70. PubMed ID: 26508680
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brain natriuretic peptide as a marker of left ventricular hypertrophy in patients with aortic stenosis.
    Orlowska-Baranowska E; Baranowski R; Greszata L; Stepinska J
    J Heart Valve Dis; 2008 Nov; 17(6):598-605. PubMed ID: 19137789
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients.
    Sarmento-Dias M; Santos-Araújo C; Poínhos R; Oliveira B; Silva IS; Silva LS; Sousa MJ; Correia F; Pestana M
    Clin Nephrol; 2016 Mar; 85(3):135-41. PubMed ID: 26833300
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.
    deFilippi C; Wasserman S; Rosanio S; Tiblier E; Sperger H; Tocchi M; Christenson R; Uretsky B; Smiley M; Gold J; Muniz H; Badalamenti J; Herzog C; Henrich W
    JAMA; 2003 Jul; 290(3):353-9. PubMed ID: 12865376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measurement of the serum levels of serum troponins I and T, albumin and C-Reactive protein in chronic hemodialysis patients and their relationship with left ventricular hypertrophy and heart failure.
    Forghani MS; Jadidoleslami MS; Naleini SN; Rajabnia M
    Diabetes Metab Syndr; 2019; 13(1):522-525. PubMed ID: 30641758
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of hemoglobin concentration on plasma B-type natriuretic peptide level and left ventricle echocardiographics characteristics in chronic kidney disease patients.
    Rasić S; Hadzović-Dzuvo A; Tomić M; Uncanin S; Corić S
    Coll Antropol; 2009 Dec; 33 Suppl 2():141-4. PubMed ID: 20120531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.